A detailed history of Cornerstone Wealth Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Wealth Group, LLC holds 13,206 shares of BMY stock, worth $757,099. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,206
Previous 13,886 4.9%
Holding current value
$757,099
Previous $576,000 18.58%
% of portfolio
0.05%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$39.66 - $51.75 $26,968 - $35,190
-680 Reduced 4.9%
13,206 $683,000
Q2 2024

Jul 24, 2024

BUY
$40.25 - $52.99 $39,082 - $51,453
971 Added 7.52%
13,886 $576,000
Q1 2024

Apr 17, 2024

BUY
$47.98 - $54.4 $411,764 - $466,860
8,582 Added 198.06%
12,915 $700,000
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $15,562 - $18,569
-321 Reduced 6.9%
4,333 $222,000
Q3 2023

Oct 18, 2023

BUY
$57.89 - $64.73 $84,345 - $94,311
1,457 Added 45.57%
4,654 $270,000
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $4,969 - $5,517
78 Added 2.5%
3,197 $204,000
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $8,213 - $9,316
-125 Reduced 3.85%
3,119 $216,000
Q4 2022

Jan 25, 2023

BUY
$68.48 - $81.09 $1,985 - $2,351
29 Added 0.9%
3,244 $0
Q3 2022

Oct 19, 2022

BUY
$0.13 - $76.84 $30 - $17,903
233 Added 7.81%
3,215 $229,000
Q2 2022

Jul 20, 2022

BUY
$72.62 - $79.98 $10,166 - $11,197
140 Added 4.93%
2,982 $230,000
Q1 2022

Apr 25, 2022

SELL
$61.48 - $73.72 $34,920 - $41,872
-568 Reduced 16.66%
2,842 $208,000
Q4 2021

Jan 25, 2022

BUY
$53.63 - $62.52 $182,878 - $213,193
3,410 New
3,410 $213,000
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $238,606 - $268,361
-4,021 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $90,536 - $102,594
-1,568 Reduced 28.06%
4,021 $249,000
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $2.41 Million - $2.67 Million
-41,958 Reduced 88.25%
5,589 $337,000
Q2 2020

Jul 27, 2020

BUY
$54.82 - $64.09 $78,118 - $91,328
1,425 Added 3.09%
47,547 $2.8 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $513,787 - $746,652
-11,073 Reduced 19.36%
46,122 $2.57 Million
Q4 2019

Jan 28, 2020

SELL
$49.21 - $64.19 $163,721 - $213,560
-3,327 Reduced 5.5%
57,195 $3.67 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $856,683 - $1.02 Million
20,030 Added 49.47%
60,522 $3.07 Million
Q2 2019

Aug 08, 2019

BUY
$44.62 - $49.34 $1.6 Million - $1.77 Million
35,787 Added 760.62%
40,492 $1.84 Million
Q1 2019

May 02, 2019

BUY
$45.12 - $53.8 $212,289 - $253,129
4,705 New
4,705 $224,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cornerstone Wealth Group, LLC Portfolio

Follow Cornerstone Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Group, LLC with notifications on news.